1. Home
  2. ESGL vs MGX Comparison

ESGL vs MGX Comparison

Compare ESGL & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESGL
  • MGX
  • Stock Information
  • Founded
  • ESGL 1999
  • MGX 2018
  • Country
  • ESGL Singapore
  • MGX United States
  • Employees
  • ESGL N/A
  • MGX N/A
  • Industry
  • ESGL
  • MGX
  • Sector
  • ESGL
  • MGX
  • Exchange
  • ESGL Nasdaq
  • MGX NYSE
  • Market Cap
  • ESGL 71.6M
  • MGX 70.4M
  • IPO Year
  • ESGL N/A
  • MGX 2024
  • Fundamental
  • Price
  • ESGL $1.75
  • MGX $1.82
  • Analyst Decision
  • ESGL
  • MGX Strong Buy
  • Analyst Count
  • ESGL 0
  • MGX 7
  • Target Price
  • ESGL N/A
  • MGX $15.50
  • AVG Volume (30 Days)
  • ESGL 6.2K
  • MGX 452.0K
  • Earning Date
  • ESGL 12-03-2024
  • MGX 11-13-2024
  • Dividend Yield
  • ESGL N/A
  • MGX N/A
  • EPS Growth
  • ESGL N/A
  • MGX N/A
  • EPS
  • ESGL N/A
  • MGX N/A
  • Revenue
  • ESGL $6,218,838.00
  • MGX $55,080,000.00
  • Revenue This Year
  • ESGL N/A
  • MGX $0.39
  • Revenue Next Year
  • ESGL N/A
  • MGX N/A
  • P/E Ratio
  • ESGL N/A
  • MGX N/A
  • Revenue Growth
  • ESGL 20.34
  • MGX 45.13
  • 52 Week Low
  • ESGL $0.41
  • MGX $1.61
  • 52 Week High
  • ESGL $2.23
  • MGX $12.74
  • Technical
  • Relative Strength Index (RSI)
  • ESGL 43.30
  • MGX 41.84
  • Support Level
  • ESGL $1.50
  • MGX $1.61
  • Resistance Level
  • ESGL $1.88
  • MGX $2.30
  • Average True Range (ATR)
  • ESGL 0.12
  • MGX 0.19
  • MACD
  • ESGL -0.01
  • MGX -0.03
  • Stochastic Oscillator
  • ESGL 52.87
  • MGX 28.77

About ESGL ESGL Holdings Limited

ESGL Holdings Ltd Formerly Environmental Solutions Group Holdings Ltd is a waste management, treatment and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical and electroplating companies.

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).

Share on Social Networks: